Virginia Kaklamani

Virginia Kaklamani

UNVERIFIED PROFILE

Are you Virginia Kaklamani?   Register this Author

Register author
Virginia Kaklamani

Virginia Kaklamani

Publications by authors named "Virginia Kaklamani"

Are you Virginia Kaklamani?   Register this Author

83Publications

1611Reads

8Profile Views

Developing a model to predict accrual to cancer clinical trials: Data from an NCI designated cancer center.

Contemp Clin Trials Commun 2019 Sep 19;15:100421. Epub 2019 Jul 19.

Department of Medicine, UT Health Cancer Center San Antonio, San Antonio, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.conctc.2019.100421DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658414PMC
September 2019

EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer.

Future Oncol 2019 Aug 20. Epub 2019 Aug 20.

UT Health San Antonio MD Anderson Cancer Center, Division of Hematology/Oncology 7979 Wurzbach Road, San Antonio, TX 78229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0370DOI Listing
August 2019

Evaluating the Effect of a Video Education Curriculum for First Time Breast Cancer Patients: a Prospective RCT Feasibility Study.

J Cancer Educ 2019 Jul 29. Epub 2019 Jul 29.

Department of Medicine, Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13187-019-01578-3DOI Listing
July 2019

Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer.

Clin Breast Cancer 2019 Jun 3;19(3):188-196. Epub 2019 Jan 3.

Department of Medicine and Carbone Cancer Center, University of Wisconsin, Madison, WI. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.12.017DOI Listing
June 2019

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

N Engl J Med 2019 06 3;380(25):2395-2405. Epub 2019 Jun 3.

From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana-Farber Cancer Institute, Boston (R.J.G.); University of Texas, San Antonio (P.M.R.); Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada; Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.); University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O., J.A.) - both in North Carolina; Mayo Clinic, Jacksonville, FL (M.P.G.); National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L.); Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis; Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin; Washington University, St. Louis (M.J.E.); the National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and the University of Pittsburgh (A.M.B.), Pittsburgh; Emory University, Atlanta (W.C.W.); Cancer Trials Ireland, Dublin (M.M.K.); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.); Cancer Center of Kansas, Wichita (P.S.R.); Vanderbilt University, Nashville (I.A.M.); Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.); and the University of Hawaii Cancer Center, Honolulu (J.L.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1904819DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709671PMC
June 2019

Perspectives on the mechanism of action and clinical application of eribulin for metastatic breast cancer.

Future Oncol 2019 May 20;15(14):1641-1653. Epub 2019 Mar 20.

Columbia University Irving Medical Center, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0936DOI Listing
May 2019

Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors.

Cancer Discov 2019 Apr 13;9(4):482-491. Epub 2019 Mar 13.

Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-1175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445714PMC
April 2019

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

N Engl J Med 2018 Jul 3;379(2):111-121. Epub 2018 Jun 3.

From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana-Farber Cancer Institute, Boston (R.J.G.); Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada; Loyola University Chicago Stritch School of Medicine, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.); University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O.) - both in North Carolina; Mayo Clinic, Jacksonville, FL (M.P.G.); National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L., J.A.); Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis; Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin; Washington University, St. Louis (M.J.E.); National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and University of Pittsburgh (A.M.B.), Pittsburgh; Emory University, Atlanta (W.C.W.); University of Texas, San Antonio (P.M.R.); Cancer Trials Ireland, Dublin (M.M.K.); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.); Cancer Center of Kansas, Wichita (P.S.R.); Vanderbilt University, Nashville (I.A.M.); Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.); and University of Hawaii Cancer Center, Honolulu (J.L.B.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1804710
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1804710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172658PMC
July 2018

Multi-gene Panel Testing in Breast Cancer Management.

Cancer Treat Res 2018 ;173:121-140

Cancer Therapy and Research Center, University of Texas Health Science Center San Antonio, 7979 Wurzbach Road, San Antonio, TX, 78229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-70197-4_8DOI Listing
June 2018

Empowering Latina breast cancer patients to make informed decisions about clinical trials: a pilot study.

Transl Behav Med 2018 05;8(3):439-449

Institute for Health Promotion Research, UT Health San Antonio, San Antonio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/tbm/ibx083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257071PMC
May 2018

Developments in Breast Cancer 2017-2018: New Drugs, New Drug Classes-and the Prospect of More to Come.

Oncology (Williston Park) 2017 12;31(12 Suppl 1):6-7

View Article

Download full-text PDF

Source
December 2017

Efficacy of a Weight Loss Intervention for African American Breast Cancer Survivors.

J Clin Oncol 2017 Aug 19;35(24):2820-2828. Epub 2017 Jun 19.

Melinda Stolley, Anjishnu Banerjee, Alexis Visotcky, Lauren Matthews, Medical College of Wisconsin, Milwaukee WI; Patricia Sheean, Loyola University Chicago, Maywood; Ben Gerber, Claudia Arroyo, Linda Schiffer, Giamila Fantuzzi, Desmona Strahan, Roxanne Dakers, Katya Seligman, Sparkle Springfield, Angela Odoms-Young, Kent Hoskins, and Lisa Sharp, University of Illinois at Chicago; Cynthia Carridine-Andrews, Chicago Park District; Susan Hong, University of Chicago, Chicago IL; and Virginia Kaklamani, University of San Antonio, San Antonio TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.9856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562172PMC
August 2017

Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.

Oncologist 2017 05 17;22(5):507-517. Epub 2017 Mar 17.

Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0464DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423509PMC
May 2017

Clinical Implications of the Progression-Free Survival Endpoint for Treatment of Hormone Receptor-Positive Advanced Breast Cancer.

Oncologist 2016 08 2;21(8):922-30. Epub 2016 Jun 2.

Division of Hematology/Oncology, Breast Cancer Program, Cancer Therapy & Research Center, School of Medicine, University of Texas, San Antonio, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0366DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978550PMC
August 2016

Estrogen receptor alpha inhibits senescence-like phenotype and facilitates transformation induced by oncogenic ras in human mammary epithelial cells.

Oncotarget 2016 Jun;7(26):39097-39107

Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, Texas, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9772DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129916PMC
June 2016

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

N Engl J Med 2015 Nov 27;373(21):2005-14. Epub 2015 Sep 27.

From the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana-Farber Cancer Institute, Boston (R.J.G.); Sunnybrook Research Institute, Toronto (K.I.P.) and Juravinski Cancer Center, Hamilton, ON (T.J.W.) - both in Canada; Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.); University of North Carolina, Chapel Hill (E.C.D.), Duke University Medical Center, Durham (J.A.O.), Wake Forest University Health Service, Winston-Salem (L.I.W.), and Southeast Clinical Oncology Research Consortium, Goldsboro (J.N.A.) - all in North Carolina; Mayo Clinic, Jacksonville, FL (E.A.P.); University of Maryland School of Medicine, Baltimore (J.A.O.), and National Institutes of Health, Bethesda (J.Z., T.L.) - both in Maryland; Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.) - both in Indianapolis; Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin; Baylor College of Medicine, Houston (M.J.E.), and University of Texas, San Antonio (P.R.) - both in Texas; Washington University, St. Louis (M.J.E.); Allegheny General Hospital (S.P.) and University of Pittsburgh (A.M.B.) - both in Pittsburgh; the Department of Medical Oncology and Breast Center, Yonsei University College of Medicine, Seoul, South Korea (S.P.); Emory University, Atlanta (W.C.W.); Irish Clinical Oncology Research Group, Dublin (M.M.K.); Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.M.); Cancer Center of Kansas, Wichita (P.S.R.); Vanderbilt University, Nashville (I.A.M.); Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.); University of Hawaii Cancer Center, Honolulu (J.L.B.); and Stanford University, Stanford, CA (G.W.S.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1510764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701034PMC
November 2015

Predicting benefit from imatinib: are we close?

Leuk Lymphoma 2014 Nov 22;55(11):2421-2. Epub 2014 Apr 22.

Feinberg School of Medicine, Northwestern University , Chicago, IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.909041DOI Listing
November 2014

Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.

J Vasc Interv Radiol 2014 Oct 22;25(10):1523-32, 1532.e1-2. Epub 2014 Aug 22.

Department of Radiology and Section of Interventional Radiology, Northwestern University Feinberg School of Medicine, Chicago. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2014.07.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720166PMC
October 2014

The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies.

Oncologist 2012 31;17(11):1394-401. Epub 2012 Aug 31.

University of Athens Medical School, 75 Mikras Asias Street, Goudi 11527, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500359PMC
June 2013

Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative.

Breast Cancer Res Treat 2013 Jun 30;139(2):461-8. Epub 2013 Apr 30.

Division Hematology/Oncology, Department of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2546-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773607PMC
June 2013

Targeting angiogenesis in metastatic breast cancer.

Oncologist 2012 27;17(8):1014-26. Epub 2012 Jul 27.

Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425519PMC
April 2013

Paradigm of polyendocrine therapy in endocrine responsive breast cancer: the role of fulvestrant.

Chin Clin Oncol 2013 Mar;2(1):10

Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine of Northwestern University and the Robert H Lurie Comprehensive Cancer Center, 676 N St Clair St, Suite 850, Chicago, IL 606011, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2012.09.04DOI Listing
March 2013

A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.

J Natl Cancer Inst 2013 Jan 14;105(2):95-103. Epub 2012 Dec 14.

Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Ave, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545904PMC
January 2013

Metabolic syndrome and triple-negative breast cancer: a new paradigm.

Int J Breast Cancer 2012 15;2012:809291. Epub 2011 Oct 15.

Cancer Genetics Program, Division of Hematology/Oncology, Department of Medicine and Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/809291DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262602PMC
August 2012

Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.

Metabolism 2011 Sep 12;60(9):1234-43. Epub 2011 Mar 12.

Cancer Genetics Program, Division of Hematology/Oncology, Department of Medicine and Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.metabol.2011.01.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134585PMC
September 2011

Global experience with ixabepilone in breast cancer.

Expert Rev Anticancer Ther 2011 May;11(5):683-92

Cancer Genetics Program, Division of Hematology/Oncology, Northwestern University, 676 N St Clair St, Suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.11.41DOI Listing
May 2011

The role of the fat mass and obesity associated gene (FTO) in breast cancer risk.

BMC Med Genet 2011 Apr 13;12:52. Epub 2011 Apr 13.

Cancer Genetics Program, Division of Hematology/Oncology, Department of Medicine and Robert H, Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, 676 N St Clair st suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2350-12-52DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089782PMC
April 2011

Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal cancer risk.

Ann Hum Genet 2011 Jan 15;75(1):90-104. Epub 2010 Sep 15.

Department of Biostatistics, University of Alabama at Birmingham, 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1469-1809.2010.00605.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005151PMC
January 2011

Lessons learned from genetic testing.

JAMA 2010 Sep;304(9):1011-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2010.1263DOI Listing
September 2010

Lapatinib and breast cancer: current indications and outlook for the future.

Expert Rev Anticancer Ther 2010 Aug;10(8):1171-82

Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine of Northwestern University and the Robert H Lurie Comprehensive Cancer Center, 676 North St Clair Street, Suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.10.113DOI Listing
August 2010

Can novel genetic polymorphisms predict response to therapy in acute myeloid leukemia?

Leuk Lymphoma 2010 Jul;51(7):1161-2

Northwestern University, Feinberg School of medicine, Department of Medicine Division of Hematology/Oncology, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2010.486455DOI Listing
July 2010

Role of polymorphisms in Adamantiades-Behçet's disease.

J Rheumatol 2008 Dec 15;35(12):2376-8. Epub 2008 Oct 15.

Cancer Genetics Program, Division of Hematology/Oncology, Department of Medicine, and Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646844PMC
December 2008

Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk.

JAMA 2008 Oct;300(13):1523-31

Cancer Genetics Program, Division of Hematology and Oncology, Department of Medicine and Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.300.13.1523DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628475PMC
October 2008

Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk.

Cancer Res 2008 May;68(9):3178-84

Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-0533DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685173PMC
May 2008

Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.

Hum Mol Genet 2007 Dec 21;16(24):3128-35. Epub 2007 Sep 21.

Cancer Genetics Program, Division of Hematology/Oncology, Department of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddm274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637554PMC
December 2007

HER2-positive breast cancer: current and future treatment strategies.

Drugs 2007 ;67(9):1329-41

Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine and the Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.2165/00003495-200767090-00006
Publisher Site
http://dx.doi.org/10.2165/00003495-200767090-00006DOI Listing
August 2007

90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.

J Vasc Interv Radiol 2007 May;18(5):621-8

Department of Radiology, Northwestern University Feinberg School of Medicine, 676 N. St. Clair, Suite 800, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2007.02.019DOI Listing
May 2007

New insights into breast cancer genetics and impact on patient management.

Curr Treat Options Oncol 2007 Feb;8(1):61-73

Cancer Genetics Program, Division of Hematology/Oncology, Department of Medicine and Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-007-0021-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670199PMC
February 2007

A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX.

Expert Rev Mol Diagn 2006 Nov;6(6):803-9

Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine of Northwestern University 676 North St. Clair Street, Suite 850, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737159.6.6.803DOI Listing
November 2006

Role of efaproxiral in metastatic brain tumors.

Expert Rev Anticancer Ther 2006 Apr;6(4):477-85

Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H Lurie Comprehensive Cancer Center, 676 North Street Clair Street, Suite 850, Chicago, IL 60622, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.6.4.477DOI Listing
April 2006

Gene expression in breast cancer.

Curr Treat Options Oncol 2006 Mar;7(2):123-8

Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine of Northwestern University, 676 North St. Clair Street, Suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
March 2006

Adjuvant therapy of breast cancer.

Cancer Invest 2005 ;23(6):548-60

Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine of Northwestern University, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900500202937DOI Listing
November 2005

Transforming Growth Factor Beta and breast cancer.

Cancer Treat Res 2005 ;126:129-56

Division of Hematology/Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/0-387-24361-5_6DOI Listing
November 2005

TGFBR1*6A may contribute to hereditary colorectal cancer.

J Clin Oncol 2005 May;23(13):3074-8

Cancer Genetics Program, Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, 676 N St Clair St, Suite 880, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.00.281DOI Listing
May 2005

Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.

Cancer Res 2005 Apr;65(8):3454-61

Cancer Genetics Program, Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 676 North St. Clair Street, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-2961DOI Listing
April 2005

The assessment and management of cancer treatment-related diarrhea.

Clin Colorectal Cancer 2005 Mar;4(6):375-81; discussion 382-3

Northwestern Medical Faculty Foundation, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
March 2005

No major association between TGFBR1*6A and prostate cancer.

BMC Genet 2004 Sep 22;5:28. Epub 2004 Sep 22.

Cancer Genetics Program, Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2156-5-28DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC521683PMC
September 2004

Role of TGF-beta in cancer and the potential for therapy and prevention.

Expert Rev Anticancer Ther 2004 Aug;4(4):649-61

Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Department of Medicine, Robert H Lurie Comprehensive Cancer Center, 676 N. St Clair Street, Suite 880, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.4.4.649DOI Listing
August 2004

New targeted therapies in breast cancer.

Semin Oncol 2004 Apr;31(2 Suppl 4):20-5

Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
April 2004

The effect of smoking on the clinical features of Adamantiades-Behçet's disease.

Adv Exp Med Biol 2003 ;528:323-7

McGaw Medical Center, Northwestern University, Chicago, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/0-306-48382-3_64DOI Listing
December 2003

TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.

J Clin Oncol 2003 Sep;21(17):3236-43

Cancer Genetics Program, Division of Hematology/Oncology, Evanston Northwestern Healthcare, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.11.524DOI Listing
September 2003

TGF-beta signaling alterations in cancer.

Cancer Treat Res 2003 ;115:73-94

Division of Hematology/Oncology, Department of Medicine, Northwestern University Medical School, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/0-306-48158-8_3DOI Listing
July 2003

Role of capecitabine (Xeloda) in breast cancer.

Expert Rev Anticancer Ther 2003 Apr;3(2):137-44

Department of Medicine, Feinberg School of Medicine, Northwestern University, Robert H Lurie Comprehensive Cancer Center, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.3.2.137DOI Listing
April 2003

Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer?

Clin Breast Cancer 2003 Apr;4 Suppl 1:S26-33

Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
April 2003

Advances in adjuvant chemotherapy for breast cancer: the role of taxanes.

J Natl Compr Canc Netw 2003 Jan;1 Suppl 1:S107-18

Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
January 2003